资讯

智通财经APP获悉,美国医药巨头礼来(LLY.US)正在加大对廉价 Zepbound 仿制品的打击力度,该公司在官网宣布,将降低畅销减肥药Zepbound“小瓶装”的价格。
智通财经APP获悉,全球糖尿病巨头诺和诺德(NVO.US)股价周四在哥本哈根暴跌,原因在于其竞争对手礼来(LLY.US)推出的一种新药Zepbound在减肥和控制血糖 ...
财联社5月12日讯(编辑 牛占林)当地时间周日(5月11日),礼来公布的对比试验数据显示,其减肥药物Zepbound的减重效果,要比竞争对手诺和诺德的 ...
To learn more about the dosages for all uses of these drugs, see the Zepbound dosage article and Wegovy dosage article. If you have questions about dosing when switching from Wegovy to Zepbound or ...
据证券时报,礼来公司的畅销减肥药Zepbound和糖尿病治疗药物Mounjaro第三季度的销售额低于预期,尽管这两种药物已基本从美国的普遍短缺中恢复过来。
In interviews, patients said that they had specifically sought out Zepbound and didn’t want to switch. “I chose Zepbound with my doctor,” said Carl Houde, 49, of Saugus, Mass. “For that to ...
Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now she fears a deal struck between CVS Health Corp. and Novo Nordisk A/S ...
Limited by Insurance: Tens of thousands of Americans will soon be forced by their health insurance to switch from Zepbound, in spite of research that found that it resulted in more weight loss ...
Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a 72-week clinical trial. The randomized, controlled trial — called ...
Zepbound (tirzepatide) is a brand-name drug prescribed to help with weight management or obstructive sleep apnea in certain adults. Zepbound comes as a solution for injection under the skin ...